9GF-99835-20374
2 vaccinations
4 coded responses
10 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 208 / MD
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Survey response — day 0, dose 1MedDRA: Sneezing — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: Sneezing since vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · HeadacheFree text: Itching scalp and bodyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
- 2020-12-30
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Melanocytic naevus, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: No symptoms but all of a sudden one of my mole in the upper back grew bigger like overnight growth. I took photos. The new growth is lighter in color and can easily be seen as a new raised bump underneath the black mole, like a fluid filled bleb · Healthcare visit (other): Scheduling a visit with a dermatologist. Sudden increased growth noted on 1/5/2021.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-02-03
-
2021-02-10
Call successfulParticipant prefers to complete VAERS report online
- 2021-02-15
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Pruritus, Self-medication — Feeling: GoodFree text: Increased itching and using more of ClaritinMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Sneezing since vaccination
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Itching scalp and body
Release 1 — day 14, dose 1
Symptoms: No symptoms but all of a sudden one of my mole in the upper back grew bigger like overnight growth. I took photos. The new growth is lighter in color and can easily be seen as a new raised bump underneath the black mole, like a fluid filled bleb
Healthcare visit (other): Scheduling a visit with a dermatologist. Sudden increased growth noted on 1/5/2021.
Release 7 — 3 months, dose 2
Symptoms: Increased itching and using more of Claritin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Specialist consultation | ○ | ○ | ○ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Melanocytic naevus | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release